BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
MDM2
,
Response to oxidative stress
,
Diabetes mellitus
,
Kidney
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cdk2 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
Hepatocellular carcinoma HepG2 cells with siRNA knockdown of the nuclear protein WEE1
Prostate cancer cell line (LNCaP) treated with trichostatin A or roscovitine, or EZH2 knockdown
Lung cancer A549 cells overexpressing miR-509-3p mimic
Breast cancer T-47D cells overexpressing PGR-B, G2/M phase synchronized, and treated with R-5020
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical CDK2 Inhibitors: Trends to Selectivity and Efficacy.
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) In…
Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors.
2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Desig…
Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against me…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With M…
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients
(VELA) Study of BLU-222 in Advanced Solid Tumors
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
Study of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harbori…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ